These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 6715121

  • 1. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
    Fehér J, Toncsev H, Sréter L, Cornides A, Kiss A.
    Int J Tissue React; 1984; 6(1):75-80. PubMed ID: 6715121
    [Abstract] [Full Text] [Related]

  • 2. Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.
    Fehér J, Toncsev H, Fehér E, Kiss A, Vasady A.
    Int J Tissue React; 1981 Mar; 3(1):31-7. PubMed ID: 7287055
    [Abstract] [Full Text] [Related]

  • 3. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L, Dávid K, Nagy I, Stotz G, Kelemen JT.
    Acta Physiol Hung; 1984 Mar; 64(3-4):461-70. PubMed ID: 6152370
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986 Mar; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 5. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A, Paál M, Kádas I, Kerekes E, Jávor T.
    Acta Med Hung; 1983 Mar; 40(1):17-24. PubMed ID: 6664741
    [Abstract] [Full Text] [Related]

  • 6. Glycohydrolases and lysosomal stability in adjuvant induced arthritis.
    Arumugham R, Bose SM.
    Ital J Biochem; 1980 Mar; 29(1):27-40. PubMed ID: 7380646
    [Abstract] [Full Text] [Related]

  • 7. Studies on the lysosomal enzyme system of the liver in rats undergoing swimming training.
    Toncsev H, Frenkl R.
    Int J Sports Med; 1984 Jun; 5(3):152-5. PubMed ID: 6746178
    [Abstract] [Full Text] [Related]

  • 8. [Clinical and experimental studies on changes in lysosomal enzyme activity in fatty livers (author's transl)].
    Yamada J.
    Hokkaido Igaku Zasshi; 1978 May; 53(3):191-204. PubMed ID: 711125
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A, Horváth T, Beró T, Kádas I, Pakodi F, Jávor T.
    Acta Physiol Hung; 1984 May; 64(3-4):449-54. PubMed ID: 6152369
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of chronic hepatitis patients with catergen].
    Karkishchenko NN, Okorokov AN, Fedorov NE, Laktionova AA, Sidorenko LF.
    Ter Arkh; 1986 May; 58(2):76-9. PubMed ID: 3704946
    [Abstract] [Full Text] [Related]

  • 11. Changes in lysosomal enzyme activities recognized in granulocytes from patients with carcinomas of the gastrointestinal tract.
    Okada T, Taniguchi T, Kitsuta T, Kiyohashi A, Okabe H.
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct 20; 23(10):2559-67. PubMed ID: 3209925
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M, Kisfaludy S, Szalay F.
    Acta Physiol Hung; 1984 Oct 20; 64(3-4):455-60. PubMed ID: 6397971
    [Abstract] [Full Text] [Related]

  • 13. Influence of bioflavonoids on lysosomal acid hydrolases and lysosomal stability.
    Rao CN, Rao VH, Steinmann B.
    Ital J Biochem; 1981 Oct 20; 30(1):46-53. PubMed ID: 7251340
    [Abstract] [Full Text] [Related]

  • 14. Acute carbon tetrachloride induced lysosomal membrane damage and the membrane protecting effect of a new dihydroquinoline-type antioxidant.
    Toncsev H, Pollák Z, Kiss A, Sréter L, Fehér J.
    Int J Tissue React; 1982 Oct 20; 4(4):325-30. PubMed ID: 7169303
    [Abstract] [Full Text] [Related]

  • 15. Comparison of isoproterenol-induced changes in lysosomal enzyme activity in vivo and in vitro.
    Macicková T, Navarová J, Urbancíkova M, Horáková K.
    Gen Physiol Biophys; 1999 Oct 20; 18 Spec No():86-91. PubMed ID: 10703725
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo demonstration of the cytoprotective effect of (+)-cyanidanol-3.
    Altorjay I, Dalmi L, Sári B.
    Acta Physiol Hung; 1984 Oct 20; 64(3-4):471-4. PubMed ID: 6532130
    [Abstract] [Full Text] [Related]

  • 17. The effect of (+) --cyanidanol on lysosomal enzymes of I-cell fibroblasts.
    Tavella D, Donnelly PV, Di Ferrante N.
    Tex Rep Biol Med; 1976 Oct 20; 34(2-4):307-14. PubMed ID: 20673
    [Abstract] [Full Text] [Related]

  • 18. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G, Boda Z, Dalmi L, Weisz G, Misz M, Beck P.
    Ther Hung; 1984 Oct 20; 32(1):19-25. PubMed ID: 6571189
    [No Abstract] [Full Text] [Related]

  • 19. Antishock effect of gabexate mesilate (FOY).
    Oda T, Miyawaki T, Sameshima T, Miyao J, Arai Y, Yoshimine K, Yoshimura N.
    Prog Clin Biol Res; 1983 Oct 20; 111():293-307. PubMed ID: 6408649
    [Abstract] [Full Text] [Related]

  • 20. Effect of endotracheal anaesthesia on the activity of lysosomal enzymes in peripheral blood granulocytes.
    Gaszynski W, Sulowska Z, Szpunar M, Siwik J, Kralkowski K.
    Anaesth Resusc Intensive Ther; 1976 Oct 20; 4(1):3-9. PubMed ID: 970615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.